Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Oñate Á[au]:

Search results

Items: 1 to 50 of 54

1.

Editorial: Molecular Vaccines Against Pathogens in the Post-genomic Era.

Oñate AA, Wan Y, Moreno A.

Front Cell Infect Microbiol. 2020 Jan 22;9:443. doi: 10.3389/fcimb.2019.00443. eCollection 2019. No abstract available.

2.

Prevalence of STOP BANG questionnaire and association with major cardiovascular events in hospitalized population: is it enough with currently used cardiovascular risk measurements?

Labarca G, Valdivia G, Oñate A, Navarrete C, Araya J, Fernandez-Bussy I, Dreyse J, Jorquera J.

Sleep Med. 2019 Sep;61:82-87. doi: 10.1016/j.sleep.2019.02.019. Epub 2019 Mar 13.

PMID:
31416696
3.

Cumulative acquisition of pathogenicity islands has shaped virulence potential and contributed to the emergence of LEE-negative Shiga toxin-producing Escherichia coli strains.

Montero DA, Canto FD, Velasco J, Colello R, Padola NL, Salazar JC, Martin CS, Oñate A, Blanco J, Rasko DA, Contreras C, Puente JL, Scheutz F, Franz E, Vidal RM.

Emerg Microbes Infect. 2019;8(1):486-502. doi: 10.1080/22221751.2019.1595985.

4.

Synthesis and characterization of CAPE derivatives as xanthine oxidase inhibitors with radical scavenging properties.

Choi W, Villegas V, Istre H, Heppler B, Gonzalez N, Brusman N, Snider L, Hogle E, Tucker J, Oñate A, Oñate S, Ma L, Paula S.

Bioorg Chem. 2019 May;86:686-695. doi: 10.1016/j.bioorg.2019.02.049. Epub 2019 Feb 22.

PMID:
30831530
5.

Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.

Gómez L, Alvarez F, Betancur D, Oñate A.

Vaccine. 2018 May 17;36(21):2928-2936. doi: 10.1016/j.vaccine.2018.04.014. Review.

PMID:
29685597
6.

A Novel Patient Recruitment Strategy: Patient Selection Directly from the Community through Linkage to Clinical Data.

Zimmerman LP, Goel S, Sathar S, Gladfelter CE, Onate A, Kane LL, Sital S, Phua J, Davis P, Margellos-Anast H, Meltzer DO, Polonsky TS, Shah RC, Trick WE, Ahmad FS, Kho AN.

Appl Clin Inform. 2018 Jan;9(1):114-121. doi: 10.1055/s-0038-1625964. Epub 2018 Feb 14.

7.

Multivalent Fusion DNA Vaccine against Brucella abortus.

Gómez L, Llanos J, Escalona E, Sáez D, Álvarez F, Molina R, Flores M, Oñate A.

Biomed Res Int. 2017;2017:6535479. doi: 10.1155/2017/6535479. Epub 2017 Sep 7.

8.

Immunogenicity of a Multi-Epitope DNA Vaccine Encoding Epitopes from Cu-Zn Superoxide Dismutase and Open Reading Frames of Brucella abortus in Mice.

Escalona E, Sáez D, Oñate A.

Front Immunol. 2017 Feb 9;8:125. doi: 10.3389/fimmu.2017.00125. eCollection 2017.

9.

Immunogenicity and Protective Response Induced by Recombinant Plasmids Based on the BAB1_0267 and BAB1_0270 Open Reading Frames of Brucella abortus 2308 in BALB/c Mice.

Gómez LA, Alvarez FI, Fernández PA, Flores MR, Molina RE, Coloma RF, Oñate AA.

Front Cell Infect Microbiol. 2016 Sep 29;6:117. eCollection 2016.

10.

Vaccination with DNA Encoding Truncated Enterohemorrhagic Escherichia coli (EHEC) Factor for Adherence-1 Gene (efa-1') Confers Protective Immunity to Mice Infected with E. coli O157:H7.

Riquelme-Neira R, Rivera A, Sáez D, Fernández P, Osorio G, del Canto F, Salazar JC, Vidal RM, Oñate A.

Front Cell Infect Microbiol. 2016 Jan 20;5:104. doi: 10.3389/fcimb.2015.00104. eCollection 2015.

11.

Mucosal immunization of BALB/c mice with DNA vaccines encoding the SEN1002 and SEN1395 open reading frames of Salmonella enterica serovar Enteritidis induces protective immunity.

Bello J, Sáez D, Escalona E, Velozo P, Santiviago CA, Contreras I, Oñate Á.

Epidemiol Infect. 2016 Jan;144(2):247-56. doi: 10.1017/S095026881500120X. Epub 2015 Jun 26.

PMID:
26113459
12.

TleA, a Tsh-like autotransporter identified in a human enterotoxigenic Escherichia coli strain.

Gutiérrez D, Pardo M, Montero D, Oñate A, Farfán MJ, Ruiz-Pérez F, Del Canto F, Vidal R.

Infect Immun. 2015 May;83(5):1893-903. doi: 10.1128/IAI.02976-14. Epub 2015 Feb 23.

13.

Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.

Retamal-Díaz A, Riquelme-Neira R, Sáez D, Rivera A, Fernández P, Cabrera A, Guzmán CA, Oñate A.

Clin Vaccine Immunol. 2014 Nov;21(11):1474-80. doi: 10.1128/CVI.00554-14. Epub 2014 Aug 27.

14.

Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

Montero D, Orellana P, Gutiérrez D, Araya D, Salazar JC, Prado V, Oñate A, Del Canto F, Vidal R.

Infect Immun. 2014 Nov;82(11):4767-77. doi: 10.1128/IAI.02030-14. Epub 2014 Aug 25.

15.

Roles of genomic island 3 (GI-3) BAB1_0267 and BAB1_0270 open reading frames (ORFs) in the virulence of Brucella abortus 2308.

Ortiz-Román L, Riquelme-Neira R, RobertoVidal, Oñate A.

Vet Microbiol. 2014 Aug 6;172(1-2):279-84. doi: 10.1016/j.vetmic.2014.05.005. Epub 2014 May 14.

PMID:
24928771
16.

Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors.

Amato E, Bankemper T, Kidney R, Do T, Onate A, Thowfeik FS, Merino EJ, Paula S, Ma L.

Bioorg Med Chem. 2014 Jan 1;22(1):126-34. doi: 10.1016/j.bmc.2013.11.045. Epub 2013 Dec 5.

17.

Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB/c mice.

Riquelme-Neira R, Retamal-Díaz A, Acuña F, Riquelme P, Rivera A, Sáez D, Oñate A.

Vaccine. 2013 Aug 12;31(36):3663-7. doi: 10.1016/j.vaccine.2013.06.013. Epub 2013 Jul 5.

PMID:
23834811
18.

Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.

Sislema-Egas F, Céspedes S, Fernández P, Retamal-Díaz A, Sáez D, Oñate A.

Vaccine. 2012 Nov 26;30(50):7286-91. doi: 10.1016/j.vaccine.2012.09.039. Epub 2012 Sep 28.

PMID:
23026687
19.

Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.

Sáez D, Fernández P, Rivera A, Andrews E, Oñate A.

Vaccine. 2012 Feb 8;30(7):1283-90. doi: 10.1016/j.vaccine.2011.12.088. Epub 2012 Jan 2.

PMID:
22222868
20.

Roles of genomic island 3 (GI-3) BAB1_0278 and BAB1_0263 open reading frames (ORFs) in the virulence of Brucella abortus in BALB/c mice.

Céspedes S, Salgado P, Retamal-Díaz A, Vidal R, Oñate A.

Vet Microbiol. 2012 Apr 23;156(1-2):1-7. doi: 10.1016/j.vetmic.2011.09.025. Epub 2011 Oct 1.

PMID:
22005180
21.

Characterization of genomic island 3 and genetic variability of Chilean field strains of Brucella abortus.

Céspedes S, Salgado P, Valenzuela P, Vidal R, Oñate AA.

J Clin Microbiol. 2011 Jul;49(7):2461-9. doi: 10.1128/JCM.01176-10. Epub 2011 May 4.

22.

Cloning, expression and immunogenicity of the translation initiation factor 3 homologue of Brucella abortus.

González M, Andrews E, Folch H, Sáez D, Cabrera A, Salgado P, Oñate A.

Immunobiology. 2009;214(2):113-20. doi: 10.1016/j.imbio.2008.07.004. Epub 2008 Aug 26.

PMID:
19167989
23.

Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.

Cabrera A, Sáez D, Céspedes S, Andrews E, Oñate A.

Immunobiology. 2009;214(6):467-74. doi: 10.1016/j.imbio.2008.11.016. Epub 2009 Jan 17.

PMID:
19150742
24.

Effect of white cell counts on the presence of human herpes simplex virus type-1 in saliva of pediatric oncology patients.

Sepúlveda E, Rojas IG, Brethauer U, Maulén NP, Muñoz M, Kirsten L, Oñate A, Fernández E, Le Fort P, Rojas J.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 May;105(5):583-8. doi: 10.1016/j.tripleo.2007.12.035.

PMID:
18442743
25.

Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle.

Sáez D, Guzmán I, Andrews E, Cabrera A, Oñate A.

Vet Microbiol. 2008 Jun 22;129(3-4):396-403. doi: 10.1016/j.vetmic.2007.11.015. Epub 2007 Nov 22.

PMID:
18164561
27.

Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.

González-Smith A, Vemulapalli R, Andrews E, Oñate A.

Immunobiology. 2006;211(1-2):65-74. Epub 2005 Dec 27.

PMID:
16446171
28.
29.

Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells.

Muñoz-Montesino C, Andrews E, Rivers R, González-Smith A, Moraga-Cid G, Folch H, Céspedes S, Oñate AA.

Infect Immun. 2004 Apr;72(4):2081-7.

30.

A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.

Oñate AA, Céspedes S, Cabrera A, Rivers R, González A, Muñoz C, Folch H, Andrews E.

Infect Immun. 2003 Sep;71(9):4857-61.

31.
32.

Frequent exposure of mice to crude Brucella abortus proteins down-regulates immune response.

Oñate A, Andrews E, Beltran A, Eller G, Schurig G, Folch H.

J Vet Med B Infect Dis Vet Public Health. 2000 Nov;47(9):677-82.

PMID:
11244868
33.

[PRIMARY STENT IMPLANTATION IN AORTIC COARCTATION. MID-TERM FOLLOW-UP]

Alcibar J, Peña N, Oñate A, Cabrera A, Galdeano JM, Pastor E, Inguanzo R, Vitoria Y, Gómez S, Arana JI, Barrenechea JI.

Rev Esp Cardiol. 2000 Jun;52(6):797-804. Spanish.

34.

[Primary stent implantation in aortic coarctation: mid-term follow-up].

Alcibar J, Peña N, Oñate A, Cabrera A, Galdeano JM, Pastor E, Inguanzo R, Vitoria Y, Gómez S, Arana JI, Barrenechea JI.

Rev Esp Cardiol. 2000 Jun;53(6):797-804. Spanish.

35.

Stent implantation in a central aorto-pulmonary shunt.

Alcibar J, Cabrera A, Martinez P, Peña N, Oñate A.

J Invasive Cardiol. 1999 Aug;11(8):506-9.

PMID:
10745585
36.

Identification and partial characterisation of a new protective antigen of Brucella abortus.

Cespedes S, Andrews E, Folch H, Oñate A.

J Med Microbiol. 2000 Feb;49(2):165-70.

PMID:
10670567
37.

[Stent implantation in palliative central aortopulmonary shunt of congenital cardiopathies with pulmonary hypoperfusion. Experience of 2 cases].

Alcíbar J, Peña N, Cabrera A, Jiménez A, Gómez S, de la Torre J, Oñate A.

Rev Esp Cardiol. 1999 Oct;52(10):863-8. Spanish.

38.

[Occlusion of the levoatrial cardinal vein with Gianturco coils after Fontan operation].

Alcibar J, Gómez S, Vitoria Y, Jiménez A, Peña N, Oñate A, Cabrera A, Martínez P.

Rev Esp Cardiol. 1999 Sep;52(9):733-6. Spanish.

39.

Stent implantation in an adult with coarctation of the aorta in the presence of advanced secondary heart failure.

Alcibar J, Peña N, Oñate A, Gochi R, Barrenechea JI.

Tex Heart Inst J. 1999;26(2):143-7.

40.

Some immunological properties of lipopolysaccharide from Acinetobacter baumannii.

García A, Salgado F, Solar H, González CL, Zemelman R, Oñate A.

J Med Microbiol. 1999 May;48(5):479-83.

PMID:
10229545
41.

Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus.

Oñate AA, Vemulapalli R, Andrews E, Schurig GG, Boyle S, Folch H.

Infect Immun. 1999 Feb;67(2):986-8.

42.

[Experience with Palmaz stent in pulmonary branch stenosis].

Alcibar J, Ramón Rumoroso J, Cabrera A, Oñate A, Peña N, Arana JI, Barrenetxea JI, Miguel Galdeano J, Pastor E, González-Liébana J, Llorente A, Martínez P.

Rev Esp Cardiol. 1997 Mar;50(3):179-86. Spanish.

43.

[Late reopening of patent ductus arteriosus after complete closure with the Rashkind prosthesis. Possible traumatic origin].

Alcibar J, Gochi R, Oñate A, Barrenetxea JI, Ramón Rumoroso J, Salazar H, Jiménez A, Rodrigo D, González-Liébana J, Peña N, Cembellín JC.

Rev Esp Cardiol. 1997 Feb;50(2):133-6. Spanish.

44.

[Angioplasty of the stenotic Blalock-Taussig].

Alcíbar J, Cabrera A, Oñate A, Galdeano JM, Rumoroso JR, Pastor E, Eneriz MA, Arana JI, Llorente A, Martínez P.

Rev Esp Cardiol. 1994 Dec;47(12):819-23. Spanish.

PMID:
7855377
45.

[The angioplasty of a postsurgical obstruction of the superior vena cava].

Alcibar J, Oñate A, Cabrera A, Pastor E, Galdeano J, Inguanzo R, Peña N, Arriola J.

Rev Esp Cardiol. 1994 Mar;47(3):195-7. Spanish.

PMID:
8184172
46.

[The transcatheter closure of the persistent ductus arteriosus in an adult].

Alcíbar J, Inguanzo R, Oñate A, Sainz-Pardo N, Gochi R, Arriola J, Peña N, Montes K.

Rev Esp Cardiol. 1993 Jan;46(1):44-6. Spanish.

PMID:
8430239
47.

Balloon dilation of tricuspid and pulmonary valves in carcinoid heart disease.

Oñate A, Alcibar J, Inguanzo R, Peña N, Gochi R.

Tex Heart Inst J. 1993;20(2):115-9.

48.
49.

[Anomalous origin of the coronary artery in the pulmonary artery. Report of a case in adulthood].

Peña R, Alcibar J, Cabrera A, Izquierdo MA, Inguanzo R, Oñate A.

Rev Esp Cardiol. 1990 Aug-Sep;43(7):500-2. Spanish.

PMID:
2093965
50.

[Patch angioplasty in isolated left main coronary artery stenosis].

Ortiz de Salazar A, Aramendi JI, Juanena C, Oñate A, Alcíbar J, Agosti J.

Rev Esp Cardiol. 1990 Jun-Jul;43(6):417-9. Spanish.

PMID:
2236790

Supplemental Content

Support Center